Drug-Eluting Stent System Gains FDA Approval

Share on FacebookTweet about this on TwitterShare on LinkedIn

A next-generation drug-eluting stent system (PROMUS Element Plus Platinum Chromium Stent System, Boston Scientific) has received FDA approval for use in patients with coronary artery disease. The device has been shown to improve cardiac performance and features an innovative platinum chromium platform.

Source: Boston Scientific.

Submit a Comment

Your email address will not be published. Required fields are marked *

5 × 5 =